Related Experiment Videos
Use of pretreatment prostate specific antigen doubling time to predict outcome after radical prostatectomy
1Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Prostate Cancer and Prostatic Diseases
|December 24, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomy.
Prostate cancer and prostatic diseases·2002
Molecular followup of newly diagnosed bladder cancer using urine samples.
The Journal of urology·2001
[The role of tumor markers in the treatment of germ cell tumor].
Gan to kagaku ryoho. Cancer & chemotherapy·2001
Prevention and treatment of urothelial premalignant and malignant lesions.
Scandinavian journal of urology and nephrology. Supplementum·2001
Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.
Prostate cancer and prostatic diseases·2026
Oncological and functional outcomes of focal irreversible electroporation for localised prostate cancer: a single institution series of 171 cases.
Prostate cancer and prostatic diseases·2026
Correlation of intraprostatic lesional SUVmax during PSMA PET/CT and adverse pathology at radical prostatectomy.
Prostate cancer and prostatic diseases·2026
Prostate size and its effect on sexual function following convective water vapor thermal therapy.
Prostate cancer and prostatic diseases·2026
Successful cabazitaxel desensitization after severe taxane hypersensitivity reactions: a brief report.
Prostate cancer and prostatic diseases·2026
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.
Prostate cancer and prostatic diseases·2026
Individualized breast cancer survival prediction in clinical practice: a SEER-derived interactive web tool integrating molecular and anatomical factors.
Journal of public health (Oxford, England)·2026
A Myeloid-Specific Endogenous TRP1-CAR Knock-in Mouse Model for Melanoma-Targeted Immunotherapy.
ImmunoTargets and therapy·2026
Clinicopathological Features and Statistical Associations in Squamous Cell Carcinoma of the Lip.
Current health sciences journal·2026
Sex-Specific Predictive Value of Obesity-Related Indicators for Diabetic Kidney Disease in Type 2 Diabetes Mellitus.
Diabetes, metabolic syndrome and obesity : targets and therapy·2026
Prognostic Value of FST and Relevance to Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
World journal of otorhinolaryngology - head and neck surgery·2026